← All organizations

Inotrem

For profitWebsite ↗

Also known as: CEO and Medical Officer | Inotrem | INOTREM SA

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jun 30, 2020

Timeline

2010s

Jun 1, 2013
Inotrem— Founded

Drugs by trial phase (1 distinct, 4 trials)

Phase 2 (1 own, 0 via acquisition)

nangibotide

Indications

Studied for

Recent trials (7)

NCT04429334Study chairPhase 2Jun 30, 2020
NCT04429334Lead sponsorPhase 2Jun 30, 2020
NCT04055909Study directorPhase 2Nov 30, 2019
NCT04055909Lead sponsorPhase 2Nov 30, 2019
NCT03158948Lead sponsorPhase 2Jun 1, 2017
NCT03463044Study directorPhase 1Apr 1, 2016
NCT03463044Lead sponsorPhase 1Apr 1, 2016

Details

Founded: Paris, FR Jun 1, 2013
Last known activity: Jun 30, 2020